Your browser doesn't support javascript.
loading
MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With Pancreatic Acinar Cell Carcinoma.
McEvoy, Christopher R; Kee, Damien; Prall, Owen W J; Clay, Timothy D; Scott, Clare; Backhouse, Anastasia; Fox, Stephen B; Fellowes, Andrew P; Xu, Huiling.
Afiliação
  • McEvoy CR; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Kee D; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Prall OWJ; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Clay TD; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Scott C; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Backhouse A; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Fox SB; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Fellowes AP; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
  • Xu H; Christopher R. McEvoy, PhD, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Damien Kee, MBBS, DMedSc, Peter MacCallum Cancer Centre, Melbourne, and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Owen W.J. Prall, MBBS, PhD, Peter MacCallum Canc
JCO Precis Oncol ; 3: 1-2, 2019 Dec.
Article em En | MEDLINE | ID: mdl-35100731
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article